Compare CVI & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CVI | LGND |
|---|---|---|
| Founded | 1906 | 1987 |
| Country | United States | United States |
| Employees | N/A | 68 |
| Industry | Integrated oil Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.7B |
| IPO Year | 2006 | N/A |
| Metric | CVI | LGND |
|---|---|---|
| Price | $28.14 | $221.63 |
| Analyst Decision | Strong Sell | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | $26.67 | ★ $245.00 |
| AVG Volume (30 Days) | ★ 1.2M | 146.4K |
| Earning Date | 05-20-2026 | 01-01-0001 |
| Dividend Yield | ★ 5.75% | N/A |
| EPS Growth | ★ 350.00 | N/A |
| EPS | ★ 0.27 | N/A |
| Revenue | ★ $7,162,000,000.00 | N/A |
| Revenue This Year | N/A | $0.74 |
| Revenue Next Year | $2.26 | $19.04 |
| P/E Ratio | $95.19 | ★ $76.27 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $15.10 | $93.58 |
| 52 Week High | $41.67 | $216.21 |
| Indicator | CVI | LGND |
|---|---|---|
| Relative Strength Index (RSI) | 66.72 | 71.06 |
| Support Level | $25.87 | $179.55 |
| Resistance Level | $28.95 | N/A |
| Average True Range (ATR) | 1.14 | 8.59 |
| MACD | 0.50 | 2.75 |
| Stochastic Oscillator | 99.94 | 83.96 |
CVR Energy Inc is a holding company that engages in petroleum refining and nitrogen fertilizer manufacturing through its subsidiaries. Subsidiaries include several complex, full-coking crude oil refineries, along with a crude oil gathering system, pipelines and storage tanks, and marketing and supply. The company's refineries can process blends of a variety of crude oil ranging from heavy sour to light sweet crude oil. Crude oil for CVR's refineries is supplied through its wholly-owned gathering system and pipeline. From its refineries, CVR supplies products through tanker trucks directly to customers located in close geographic proximity and customers at throughput terminals. The company's customers include retailers, railroads, and farm cooperatives.
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.